Clinical Trial Keywords
Myasthenia Gravis
Selected Publications
View all on PubMed
Palma, J.-A., Roda, R., Norcliffe-Kaufmann, L., & Kaufmann, H. (2015). Increased frequency of rhabdomyolysis in familial dysautonomia. Muscle & Nerve.
Hirst, J., Edgar, J. R., Esteves, T., Darios, F., Madeo, M., Chang, J., Robinson, M. S. (2015). Loss of AP-5 results in accumulation of aberrant endolysosomes: defining a new type of lysosomal storage disease. Human Molecular Genetics.
Roda, R. H., Schindler, A. B., Blackstone, C., Mammen, A. L., Corse, A. M., & Lloyd, T. E. (2014). Laing distal myopathy pathologically resembling inclusion body myositis. Annals of Clinical and Translational Neurology, 1(12), 1053–1058.
Roda, R. H., Rinaldi, C., Singh, R., Schindler, A. B., & Blackstone, C. (2014). Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, 21(9), 1627–1631.
Vester, A., Velez-Ruiz, G., McLaughlin, H. M., NISC Comparative Sequencing Program, Lupski, J. R., Talbot, K., … Antonellis, A. (2013). A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Human Mutation, 34(1), 191–199.
Kageyama, Y., Zhang, Z., Roda, R., Fukaya, M., Wakabayashi, J., Wakabayashi, N., … Sesaki, H. (2012). Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. The Journal of Cell Biology, 197(4), 535–551.
Roda, R. H., Gallia, G. L., Eberhart, C. G., Weingart, J. D., & Laterra, J. (2009). Epilepsy and temporal lobe injury after skull base proton beam therapy. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, 16(9), 1220–1221.
Tan, K., Roda, R., Ostrow, L., McArthur, J., & Nath, A. (2009). PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology, 72(17), 1458–1464.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.